Global Hospital-acquired infection Diagnostics Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of 7.5% - ResearchAndMarkets.com

DUBLIN--()--The "Hospital-acquired infection Diagnostics Market by Product - Global Opportunity Analysis and Industry Forecast, 2017-2023" report has been added to ResearchAndMarkets.com's offering.

The hospital-acquired infection diagnostics market was valued at $2,571 million in 2016, and is expected to reach at $4,311 million by 2023, registering a CAGR of 7.5% from 2017 to 2023.

Hospital-acquired infections are type of infections acquired during hospitalization and are commonly known as nosocomial infection. These infections can be acquired in hospital, nursing home, rehabilitation facility, outpatient clinic, or other clinical settings. They can be acquired from an infected patient, outside environment, or from a staff of that facility. The hospital-acquired infection diagnostics market is primarily driven by the growth in awareness among healthcare workers and proposed government initiatives by many governmental organizations.

The hospital-acquired infection diagnostics market is segmented based on product, test type, application, infection type, end user and region. Based on product this market is segmented into instrument and reagents and consumables. Based on test type, the market is classified into molecular diagnostics, urinalysis, and immunoassay. Based on application, the market is divided into disease testing and drug resistance testing. Further, based on infection type, it is classified into hospital acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal Infections, urinary tract infections (UTI), and others.

Companies Mentioned:

  • Abbott Laboratories
  • AdvanDX
  • Alere Inc.
  • AstraZeneca plc
  • Bayer Schering Pharma LLC
  • Becton Dickinson & Company
  • Cepheid Inc.
  • Roche AG
  • Daiichi Sankyo
  • Hologic, Inc.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Overview

4 Hospital Acquired Infection Diagnostics Market, By Product

5 Hospital Acquired Infection Diagnostics Market, By Test Type

6 Hospital Acquired Infection Diagnostics Market, By Application

7 Hospital Acquired Infection Diagnostics Market, By Infection Type

8 Hospital Acquired Infection Diagnostics Market, By End User

9 Hospital Acquired Infection Diagnostics Market, By Geography

10 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/r2qtjh/global?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, Infectious Disease Testing

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, Infectious Disease Testing